Navigation Links
Savient Provides Update on Pegloticase BLA
Date:2/12/2009

ate," said Hamelin.

KRYSTEXXA(TM) as a tradename was found to be acceptable by both the FDA and The European Medicines Agency (EMEA).

Company Hosts Conference Call

The Company will host a conference call and webcast today, Thursday, February 12, 2009 at 7:00 PM ET to discuss the status of the BLA and the amendments filed with the FDA. A question and answer period will follow the Company's prepared remarks. Both the live and archived web cast can be accessed from the Investor Relations page of Savient's website at http://www.savient.com.

A digital recording of the web cast will be available within two hours following the conclusion of the call and will be available for 14 days. To access the recording, use the Dial-In Number and the Conference ID listed below.

Dial: (888) 802-8577 (U.S. participants) or (973) 935-8754 (International participants).

Conf ID: 85467097

ABOUT KRYSTEXXA (pegloticase)

KRYSTEXXA (pegloticase) (formerly referred to as Puricase(R)) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials assessed the safety and efficacy of a six-month course of pegloticase therapy in patients with treatment-failure gout, under the auspices of an SPA from the FDA. Savient has licensed exclusive worldwide rights to the technology related to KRYSTEXXA (pegloticase) from Duke University and Mountain View Pharmaceuticals, Inc. Puricase(R) is a registered trademark of Mountain View Pharmaceuticals, Inc.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing and distributing pharmaceut
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. USAID Provides Malaria Assistance to Zimbabwe
3. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. American Dairy Provides Business Update
6. Alfacell Provides ONCONASE(R) NDA Submission Update
7. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
8. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
9. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)...  Mark Farrah Associates (MFA), www.markfarrah.com , ... the 2015 marketplace exchange projections and insights about ... According to a recent ASPE (Office of the ... Health and Human Services) report, an estimated 6.7 ... through the Marketplace as of October 2014 and ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... been dosed in a pharmacokinetic and pharmacodynamic study ... for neuropathic pain. Racemic methadone is ... various pain states and substitution therapy in opioid ...
(Date:12/19/2014)... LONDON , December 19, 2014 ... authentication services in the World announced the appointment of ... Anthony R. Vonsée, as Chief Channels and Partner Officer. ... Datanomic since 2004 through to its acquisition by Oracle ... Development Director at Geneva and ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4
... 9, 2011 CardioFocus, Inc., developer of the HeartLight ... Fibrillation (AF), announced its technology enables a Pulmonary Vein ... 86% of PVs remaining persistently isolated after three months. ... durable freedom from AF after a single procedure. ...
... Texas, May 9, 2011 Lexicon Pharmaceuticals, Inc. ... hold its Annual R&D Day on Thursday, May 12, 2011 ... York, New York.  Members of Lexicon,s senior management team will ... overview of several other preclinical programs in the company,s pipeline. ...
Cached Medicine Technology:New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 2New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 3Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day 2
(Date:12/22/2014)... 22, 2014 International efforts ... virus epidemic are receiving further support from ... nongovernmental organizations (NGOs) and other charitable organizations. ... workers, emergency responders, patients and others can ... the CmTP MediDefense system , which ...
(Date:12/22/2014)... 2014 The Bob Woodruff Foundation ... invested more than $5 million in programs and ... their families. , This includes $1.3 million in ... helping with: veteran entrepreneurship; community impact; vocational training; ... severely injured veterans. , “The needs of those ...
(Date:12/22/2014)... Naples, Florida (PRWEB) December 22, 2014 ... this holiday season, the gift of health and vitality. ... is offering its three top-selling anti-aging formulas in special ... with free rush delivery. , Each bottle contains ... digestion, areas that don't work as well as we ...
(Date:12/22/2014)... Xarelto Lawsuit News : Alonso Krangle ... granted a request to centralize pending and subsequent ... District of Louisiana. The U.S. Judicial Panel On Multidistrict ... transfer over 50 Xarelto cases–21 lawsuits and 30 potential ... for consolidation under U.S. District Judge Eldon E. Fallon. ...
(Date:12/22/2014)... Christmas is days away, and last minute ... easy solution that will please: the Sublime Gift Card ... from $25 up to $350," says Kathy Heshelow, founder of ... a wide array of skin care products and Skin Brushes." ... dates. , Gift delivery past shipping deadlines, or those ...
Breaking Medicine News(10 mins):Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4
... , One in eight new moms ... CHICAGO, Sept. 9 Up to 80 percent of women experience ... major depression within weeks of delivery. Caused by multiple factors, including ... a minor presentation, known as postpartum blues, to major depression and ...
... stem cell discovered in the prostate of adult mice ... a new study by researchers at the Herbert Irving ... NewYork-Presbyterian Hospital. Led by Michael Shen, Ph.D., professor ... Medical Center, the researchers found the rare stem cells, ...
... formulation seems to thwart pneumonia in high-risk group with ... -- A recently developed pneumonia vaccine may be more ... pulmonary disease (COPD) than the vaccine that is typically ... be an ongoing problem for people with COPD, a ...
... Mass., Sept. 9 Echo Therapeutics, Inc. (OTC Bulletin ... Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous ... for transdermal drug delivery, announced today that it has ... 2009 Annual Global Investment Conference. Patrick T. Mooney, ...
... , WASHINGTON, Sept. 9 The Advisory ... a multi-hospital system based in Coral Gables, to a ... System, Cleveland Clinic, Intermountain Health Care, Inc., Memorial Hermann ... Health System. These member health systems use the ...
... LAVAL, QC, Sept. 9 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... three separate posters will be presented at three upcoming ... trazodone formulation. , , Two posters will be ... entitled: Modeling and Simulation to Optimize Efficacy and Tolerability ...
Cached Medicine News:Health News:Prentice Women's Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 2Health News:Prentice Women's Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 3Health News:Prentice Women's Hospital Launches New Initiative to Better Identify and Address Postpartum Depression 4Health News:New type of adult stem cells found in the prostate may be involved in prostate cancer development 2Health News:New Vaccine May Work Better Against Lung Disease 2Health News:Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference 2Health News:The CRIMSON Initiative - the First Physician Performance Data Management Platform Developed By Physicians For Physicians - is Now Working With Over 200 Hospitals and Over 25,000 Doctors 2Health News:The CRIMSON Initiative - the First Physician Performance Data Management Platform Developed By Physicians For Physicians - is Now Working With Over 200 Hospitals and Over 25,000 Doctors 3Health News:The CRIMSON Initiative - the First Physician Performance Data Management Platform Developed By Physicians For Physicians - is Now Working With Over 200 Hospitals and Over 25,000 Doctors 4Health News:Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings 2Health News:Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings 3
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: